Impact Factor
2.79
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.78
169 total citations
h5-index
15
h5 depth signal
Cited share
62.6%
62 of 99
Total citations
169
Citation footprint
Metric signal
1.62
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Indonesia
47
United States
41
Iran
29
India
28
Egypt
24
Citing Fields of Research
Breast Cancer
274
Cancer & Development
32
Cosmetic Surgery
24
Oncology
20
Immunology
18
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
727
Articles tracked across the journal lifetime
Indexed publication set
99
62 cited publications
Last 12 months
2
1.0 publications/month
Open access share
100.0%
2 OA publications in the last year
Leading citing country
Indonesia
47 citing publications
Leading citing field
Breast Cancer
274 citing publications
Latest tracked publication
11 July 2026
10 recent records available
Coverage & Indexing History
v20, 2004-
v20, 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Breast Cancer
Issuing & Sponsoring Bodies
Contributor
Society for the Study of Breast Disease
Broad Categories
Gynecology
Breast Cancer
MeSH Descriptors
Breast Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/15581551261469637
Open DOI
Clinical implications of breast cancer stem cells: A review
Cancer stem cells (CSCs) are a small population of cells within a tumor which perform stem cell like functions including self-renewal, differentiation and initiation. This narrative review aims to provide an overview of the role of CSCs ...
02
DOI 10.1177/15581551251403784
Open DOI
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy
Background: Trastuzumab emtansine (T-DM1) is indicated for HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy (NAC). However, the extent of benefit T-DM1 will provide over trastuzumab plus per...
03
DOI 10.1177/15581551241312602
Open DOI
Imaging evaluation of nipple discharge: Review of literature and management considerations
Nipple discharge is a common and problematic symptom reported by many women seeking evaluation in primary care practices, surgery clinics, and breast radiology facilities. Discharge has been cited as the second to third most commonly rep...
04
DOI 10.1177/15581551251363401
Open DOI
Association between AKT1 polymorphisms and susceptibility to breast cancer in the Iranian population
Background: Akt1, a crucial component of the PI3K/Akt signaling pathway, mediates a plethora of cancer-related processes such as cell growth, proliferation, survival, apoptosis and invasion. So, the pathogenesis of various types of cance...
05
DOI 10.1177/15581551241296776
Open DOI
Circulating tumor cells as a clinical, diagnostic, and prognostic biomarker in breast cancer
Circulating tumor cells (CTCs) are cancerous cells that detach from the tumor and circulate in the bloodstream, resulting in metastasis by invading and colonizing new organs. These cells, however, pose a great significance from the clini...
06
DOI 10.1177/15581551251324069
Open DOI
Isolated breast myeloid sarcoma: A diagnostic and therapeutic challenge. A case report and literature review
Introduction: Myeloid sarcoma is a high-grade hematological malignancy that rarely occurs in the breast as the tumor is generally seen in the ribs, sternum, and orbital bones. We report a case of isolated myeloid sarcoma presenting as a ...
07
DOI 10.3233/bd-240018
Open DOI
Parametric optimization and comparative study of machine learning and deep learning algorithms for breast cancer diagnosis
Breast Cancer is the leading form of cancer found in women and a major cause of increased mortality rates among them. However, manual diagnosis of the disease is time-consuming and often limited by the availability of screening systems. ...
08
DOI 10.3233/bd-240003
Open DOI
Synchronous primary breast angiosarcoma with invasive ductal carcinoma
Primary angiosarcoma (PAS) of the breast is an extremely uncommon variant of breast malignancies. Highly aggressiveness and dismal prognosis characterize this endothelial neoplasm. We report here an unusual case of PAS of the breast occu...
09
DOI 10.3233/bd-240012
Open DOI
Breast gel based on Boswellia serrata, Betaine and myo-Inositol improves cyclic mastodynia in fertile women: A retrospective clinical study
BACKGROUND: The management of mastodynia plays a central role in improving women quality of life. Despite its high occurrence, specific therapeutic guidelines for mastalgia are still lacking. Available therapies include unspecific anti-i...
10
DOI 10.3233/bd-240019
Open DOI
Chemotherapy induced alopecia in breast cancer patients: A monocentric prospective study
INTRODUCTION: Alopecia is one of the main adverse events of chemotherapy in breast cancer. However, its impact is often ignored and underestimated by clinicians. Our aim was to evaluate the quality of life of breast cancer patients with ...
Bibliographical & Catalog Notes
Print issues ceased with 2021.
Also issued online.
Official publication of: the Society for the Study of Breast Disease.